Startupbootcamp Digital Health Berlin announces the 2018 cohort!
Startupbootcamp announces 12 startups from 8 different countries invited to join the 2018 Digital Health accelerator program in Berlin
4 Min
More 
Antibodies reduce antibiotic-induced side effects in the lungs
Researchers from Charité – Universitätsmedizin Berlin have shown that antibiotics can increase the risk of some types of pneumonia by weakening the lung’s immune system. Findings suggest that this risk may be reduced through the administration of…
2 Min
More sphingotec is adding an advanced POC testing platform to portfolio
German diagnostics company sphingotec GmbH (Hennigsdorf) and Nexus Dx (San Diego) have combined their technology platforms to market sphingotec’s CE-marked acute biomarkers penKid® and bio-ADM® on Nexus’ market-validated POC testing immunoassay…
5 Min
More Charité and BIH develop digital data processing infrastructure
Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) are pleased to announce that ‘The Virtual Brain’ neuroinformatics platform has joined the EU’s Flagship ‘Human Brain Project’. With financial support from the EU’s Horizon…
3 Min
More Leonidas Zervas Award 2018
The Leonidas Zervas Award is presented in commemoration of his outstanding contributions to peptide science. The award is given to the scientist who has made the most outstanding contributions to the chemistry, biochemistry and/or biology of…
1 Min
More CO.DON negotiates with Xintela on the establishment of a joint venture
On 5 July 2018, CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of…
1 Min
More Breakthrough in genetic engineering: Emmanuelle Charpentier wins Kavli Prize
Emmanuelle Charpentier, director at the Max Planck Institute for Infection Biology in Berlin, is among the winners of the internationally renowned Kavli prize. She is honoured for her pioneering work in developing the CRISPR-Cas9 system, a…
2 Min
More ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-Oncology Contract Development and Manufacturing Project
ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, and Pionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor…
3 Min
More RaySearch and Eckert & Ziegler BEBIG enter into partnership regarding brachytherapy
RaySearch, a medical technology company for innovative software solutions, and Eckert & Ziegler BEBIG have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare oncology information system will be integrated…
1 Min
More NOXXON ISSUES TRANCHE OF ODIRNANE BONDS
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has issued another tranche of the ODIRNANE bonds (undated bonds…
1 Min
More Show more items
